Natco Pharma Limited has informed the Exchange regarding a press release dated February 14, 2026, titled "NATCO receives approval from Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India".
Natco Pharma Limited has informed the Exchange regarding a press release dated February 14, 2026, titled "NATCO receives approval from Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India".